Macrolides - PDFSEARCH.IO - Document Search Engine

Macrolides
Results: 352

#	Item
151	LAM in the News August 2013 TSC2/TSC1 Field: Am J Respir Cell Mol Biol. 2013 Aug 15. [Epub ahead of print] Statins in LAM: Some but Add to Reading List Source URL: www.lamhealthproject.org Language: English - Date: 2013-09-04 13:49:19 Anatomy Lymphangioleiomyomatosis Macrolides Immunosuppressants Sirolimus Statin Estrogen Angiomyolipoma Medicine Rare diseases Health
152	http://www.fda.gov/cder/foi/esum/2005/21110s024,21083s019_Rapamune_Medical_BPCA.pdf Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-13 08:05:21 Macrolides Organ transplants Lactams Sirolimus Transplant rejection Tacrolimus Kidney transplantation Mycophenolic acid Chronic allograft nephropathy Medicine Immunosuppressants Chemistry
153	LAM in the News October 2013 LAM or TSC Disease Models: Hum Mol Genet. 2013 Oct 14. [Epub ahead of print] Add to Reading List Source URL: www.lamhealthproject.org Language: English - Date: 2013-11-08 12:56:06 Macrolides Angiomyolipoma Sirolimus Everolimus Mammalian target of rapamycin TSC1 RHEB TSC2 Angiogenesis Medicine Biology Immunosuppressants
154	C:DOWSKTOP302_APltr.doc Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-02-11 16:14:04 Pimecrolimus Health Eczema Atopic dermatitis Atopy Medicine Ascomycin Dermatitis Tacrolimus Immunosuppressants Type 1 hypersensitivity Macrolides
155	22334S006 Everolimus Clinical BPCA Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Macrolides Everolimus Brain tumor Kidney cancer Tuberous sclerosis Response Evaluation Criteria in Solid Tumors Renal cell carcinoma Clinical trial Medicine Health Rare diseases
156	LAM in the News April 2013 TSC2/TSC1 Field: Oncogene advance online publication 22 April 2013; doi: [removed]onc[removed]Loss of TSC2 Confers Resistance Add to Reading List Source URL: www.lamhealthproject.org Language: English - Date: 2013-05-10 13:22:41 Immunosuppressants Macrolides Rare diseases Signal transduction Mammalian target of rapamycin Sirolimus Angiomyolipoma Ceramide TSC1 Biology Medicine Chemistry
157	LAM in the News July 2013 TSC2/TSC1 Field: Mol Endocrinol. 2013 Jul 2. [Epub ahead of print] Uterine-‐Speci+ic loss of Tsc2 leads to myometr Add to Reading List Source URL: www.lamhealthproject.org Language: English - Date: 2013-08-01 12:47:33 Chemistry Rare diseases Biochemistry Lactams Sirolimus Lymphangioleiomyomatosis Everolimus Mammalian target of rapamycin Osteoprotegerin Macrolides Immunosuppressants Biology
158	Application of the QbD (Quality by Design) Approach for Coating Drug Eluting Stents (DES) Martin K. McDermott, FDA/CDRH/OSEL/DCMS & Sharmista Chatterjee, FDA/CDER/OPS/ONDQA Add to Reading List Source URL: www.fda.gov Language: English Drug-eluting stent Medical equipment Immunosuppressants Macrolides Restenosis Stent Quality by Design Everolimus QBD Medicine Implants Interventional cardiology
159	Dallas District Office Letterhead Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-02-11 16:14:02 Autoimmune diseases Type 1 hypersensitivity Health Tacrolimus Eczema Atopy Atopic dermatitis Immunosuppressive drug Kidney transplantation Medicine Immunosuppressants Macrolides
160	Assessing Cancer Risk & Assuring Safe Use of Topical Immunosuppressants: Recent History Susan K. Cummins, MD, MPH Medical Team Leader Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-03-02 16:59:25 Type 1 hypersensitivity Tacrolimus Pimecrolimus Atopy Atopic dermatitis Kidney transplantation Immunosuppressants Macrolides Medicine

UPDATE